The countdown to ASH 2017 has begun!
Join us on 8th December for our Satellite Symposium, ‘Anticoagulation: Applying Innovation in Clinical Practice’ at 1.30pm ET
59th ASH Annual Meeting & Exposition
“GARFIELD-AF shows that patients without AF symptoms (diagnosed coincidentally) have rates of death, stroke and major bleeding which are similar to those with symptoms. This suggests the presence or absence of symptoms should not influence treatment decisions for stroke reduction. Screening studies and greater awareness of the estimated 1% of the population (>65 yrs) with asympotomatic AF is needed"
- Dr Harry Gibbs presents on GARFIELD-AF data at ESC.17
Read the latest articles and watch videos showcasing data and updates from... [read more]
GARFIELD-AF is a pioneering, independent outcomes research initiative led by an international... [read more]
The GARFIELD-AF registry is a worldwide observational study of stroke prevention in... [read more]
The Steering Committee, supported by the National Coordinator Council, provides global leadership... [read more]
Provides further information on the GARFIELD-AF Score... [read more]
Atrial fibrillation (AF) is an irregular heart beat that occurs due to... [read more]
Coming soon… If you would like to be notified of when this is available click here and add your details to receive updates